{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:46:13Z","timestamp":1772689573967,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100013302","name":"King Abdullah International Medical Research Center","doi-asserted-by":"publisher","award":["SP23R\/220\/09"],"award-info":[{"award-number":["SP23R\/220\/09"]}],"id":[{"id":"10.13039\/501100013302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013302","name":"King Abdullah International Medical Research Center","doi-asserted-by":"publisher","award":["SP23R\/220\/09"],"award-info":[{"award-number":["SP23R\/220\/09"]}],"id":[{"id":"10.13039\/501100013302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013302","name":"King Abdullah International Medical Research Center","doi-asserted-by":"publisher","award":["SP23R\/220\/09"],"award-info":[{"award-number":["SP23R\/220\/09"]}],"id":[{"id":"10.13039\/501100013302","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-31192-x","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T10:44:29Z","timestamp":1765449869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Structure-based identification of compounds with potential as selective BLT1 antagonists"],"prefix":"10.1038","volume":"16","author":[{"given":"Reem A.","family":"Alkhodier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saud A.","family":"Alshamrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar S.","family":"Almutlaq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maali D.","family":"Alshammari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"31192_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/jb\/mvu078","volume":"157","author":"T Yokomizo","year":"2015","unstructured":"Yokomizo, T. Two distinct leukotriene B4 receptors, BLT1 and BLT2. J. Biochem. 157, 65\u201371 (2015).","journal-title":"J. Biochem."},{"key":"31192_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0090-6980(80)80058-X","volume":"20","author":"RMJ Palmer","year":"1980","unstructured":"Palmer, R. M. J., Stepney, R. J., Higgs, G. A. & Eakins, K. E. Chemokinetic activity of arachidonic acid lipoxygenase products on leuocytes of different species. Prostaglandins 20, 411\u2013418 (1980).","journal-title":"Prostaglandins"},{"key":"31192_CR3","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/286264a0","volume":"286","author":"AW Ford-Hutchinson","year":"1980","unstructured":"Ford-Hutchinson, A. W., Bray, M. A., Doig, M. V., Shipley, M. E. & Smith, M. J. H. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286, 264\u2013265 (1980).","journal-title":"Nature"},{"key":"31192_CR4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.2042-7158.1980.tb12985.x","volume":"32","author":"MJH Smith","year":"1980","unstructured":"Smith, M. J. H., Ford-Hutchinson, A. W. & Bray, M. A. Leukotriene B: a potential mediator of inflammation. J. Pharm. Pharmacol. 32, 517\u2013518 (1980).","journal-title":"J. Pharm. Pharmacol."},{"key":"31192_CR5","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/s41467-022-28820-9","volume":"13","author":"N Wang","year":"2022","unstructured":"Wang, N. et al. Structural basis of leukotriene B4 receptor 1 activation. Nat. Commun. 13, 1156 (2022).","journal-title":"Nat. Commun."},{"key":"31192_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-23149-1","volume":"12","author":"N Michaelian","year":"2021","unstructured":"Michaelian, N. et al. Structural insights on ligand recognition at the human leukotriene B4 receptor 1. Nat. Commun. 12, 1\u201312 (2021).","journal-title":"Nat. Commun."},{"key":"31192_CR7","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1021\/acsmedchemlett.0c00065","volume":"11","author":"M Kim","year":"2020","unstructured":"Kim, M. et al. Elucidation of mechanism for ligand efficacy at leukotriene B4 receptor 2 (BLT2). ACS Med. Chem. Lett. 11, 1529\u20131534 (2020).","journal-title":"ACS Med. Chem. Lett."},{"key":"31192_CR8","unstructured":"The UniProt Consortium. UniProt: the Universal Protein Knowledgebase in 2025. Nucleic Acids Res 1\u20139 (2024)."},{"key":"31192_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/imr.13196","volume":"317","author":"T Yokomizo","year":"2023","unstructured":"Yokomizo, T. & Shimizu, T. The leukotriene B4 receptors BLT1 and BLT2 as potential therapeutic targets. Immunol. Rev. 317, 1\u201312 (2023).","journal-title":"Immunol. Rev."},{"key":"31192_CR10","doi-asserted-by":"publisher","first-page":"L170","DOI":"10.1152\/ajplung.00212.2005","volume":"290","author":"BD Medoff","year":"2006","unstructured":"Medoff, B. D. et al. Antibody-antigen interaction in the airway drives early granulocyte recruitment through BLT1. Am. J. Physiol. Lung Cell Mol. Physiol. 290, L170\u2013L178 (2006).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"31192_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1084\/jem.20042481","volume":"202","author":"BD Medoff","year":"2005","unstructured":"Medoff, B. D. et al. BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation. J. Exp. Med. 202, 97\u2013110 (2005).","journal-title":"J. Exp. Med."},{"key":"31192_CR12","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.4049\/jimmunol.176.5.3157","volume":"176","author":"C Taube","year":"2006","unstructured":"Taube, C. et al. The leukotriene B4 receptor (BLT1) is required for effector CD8+ T cell-mediated, mast cell-dependent airway hyperresponsiveness. J. Immunol. 176, 3157\u20133164 (2006).","journal-title":"J. Immunol."},{"key":"31192_CR13","doi-asserted-by":"publisher","first-page":"21294","DOI":"10.1073\/pnas.0905209106","volume":"106","author":"H Hikiji","year":"2009","unstructured":"Hikiji, H., Ishii, S., Yokomizo, T., Takato, T. & Shimizu, T. A distinctive role of the leukotriene B4 receptor BLT1 in osteoclastic activity during bone loss. Proc. Natl. Acad. Sci. USA 106, 21294\u201321299 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"31192_CR14","doi-asserted-by":"publisher","first-page":"452","DOI":"10.4049\/jimmunol.1601346","volume":"198","author":"L Bouchareychas","year":"2017","unstructured":"Bouchareychas, L., Gr\u00f6ssinger, E. M., Kang, M., Qiu, H. & Adamopoulos, I. E. Critical role of LTB4\/BLT1 in IL-23 induced synovial inflammation and osteoclastogenesis via NF-\u03baB. J. Immunol 198, 452\u2013460 (2017).","journal-title":"J. Immunol"},{"key":"31192_CR15","doi-asserted-by":"publisher","first-page":"6254","DOI":"10.4049\/jimmunol.176.10.6254","volume":"176","author":"W-H Shao","year":"2006","unstructured":"Shao, W.-H., Del Prete, A., Bock, C. B. & Haribabu, B. Targeted disruption of leukotriene B4 receptors BLT1 and BLT2: A critical role for BLT1 in collagen-induced arthritis in mice. J. Immunol. 176, 6254\u20136261 (2006).","journal-title":"J. Immunol."},{"key":"31192_CR16","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.4049\/jimmunol.1001031","volume":"185","author":"SP Mathis","year":"2010","unstructured":"Mathis, S. P., Jala, V. R., Lee, D. M. & Haribabu, B. Nonredundant roles for leukotriene B4 receptors BLT1 and BLT2 in inflammatory arthritis. J. Immunol. 185, 3049\u20133056 (2010).","journal-title":"J. Immunol."},{"key":"31192_CR17","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1161\/CIRCULATIONAHA.105.545616","volume":"112","author":"EA Heller","year":"2005","unstructured":"Heller, E. A. et al. Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitment. Circulation 112, 578\u2013586 (2005).","journal-title":"Circulation"},{"key":"31192_CR18","doi-asserted-by":"publisher","first-page":"691","DOI":"10.4049\/jimmunol.179.1.691","volume":"179","author":"N Ahluwalia","year":"2007","unstructured":"Ahluwalia, N. et al. Inhibited aortic aneurysm formation in BLT1-deficient mice. J. Immunol. 179, 691\u2013697 (2007).","journal-title":"J. Immunol."},{"key":"31192_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12990-015-0010-9","volume":"11","author":"M Asahara","year":"2015","unstructured":"Asahara, M. et al. The absence of the leukotriene B4 receptor BLT1 attenuates peripheral inflammation and spinal nociceptive processing following intraplantar formalin injury. Mol. Pain 11, 1\u201312 (2015).","journal-title":"Mol. Pain"},{"key":"31192_CR20","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1096\/fj.10.165050","volume":"24","author":"Y Iizuka","year":"2010","unstructured":"Iizuka, Y. et al. Protective role of the leukotriene B4 receptor BLT2 in murine inflammatory colitis. FASEB J. 24, 4678\u20134690 (2010).","journal-title":"FASEB J."},{"key":"31192_CR21","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1096\/fj.15-279653","volume":"30","author":"Y Ishii","year":"2016","unstructured":"Ishii, Y. et al. Leukotriene B4 receptor type 2 (BLT2) enhances skin barrier function by regulating tight junction proteins. FASEB J. 30, 933\u2013947 (2016).","journal-title":"FASEB J."},{"key":"31192_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fj.202002640R","volume":"35","author":"T Hara","year":"2021","unstructured":"Hara, T. et al. The c-terminal region of BLT2 restricts its localization to the lateral membrane in a LIN7C-dependent manner. FASEB J 35, 1\u201311 (2021).","journal-title":"FASEB J"},{"key":"31192_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.119.263145","volume":"373","author":"Y Matsumoto","year":"2020","unstructured":"Matsumoto, Y. et al. Leukotriene B4 receptor type 2 accelerates the healing of intestinal lesions by promoting epithelial cell proliferation. J. Pharmacol Exp. Ther. 373, 1\u20139 (2020).","journal-title":"J. Pharmacol Exp. Ther."},{"key":"31192_CR24","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1084\/jem.20132063","volume":"211","author":"M Liu","year":"2014","unstructured":"Liu, M. et al. 12-Hydroxyheptadecatrienoic acid promotes epidermal wound healing by accelerating keratinocyte migration via the BLT2 receptor. J. Exp. Med. 211, 1063\u20131078 (2014).","journal-title":"J. Exp. Med."},{"key":"31192_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-13122-8","volume":"7","author":"S Iwamoto","year":"2017","unstructured":"Iwamoto, S. et al. Non-steroidal anti-inflammatory drug delays corneal wound healing by reducing production of 12-hydroxyheptadecatrienoic acid, a ligand for leukotriene B4 receptor 2. Sci. Rep. 7, 1\u201310 (2017).","journal-title":"Sci. Rep."},{"key":"31192_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.smim.2017.08.007","volume":"33","author":"L Bhatt","year":"2017","unstructured":"Bhatt, L., Roinestad, K., Van, T. & Springman, E. B. Recent advances in clinical development of leukotriene B4 pathway drugs. Semin Immunol 33, 65\u201373 (2017).","journal-title":"Semin Immunol"},{"key":"31192_CR27","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1517\/13543784.16.12.1909","volume":"16","author":"A Hicks","year":"2007","unstructured":"Hicks, A., Monkarsh, S. P., Hoffman, A. F. & Goodnow, R. Jr. Leukotriene B4 receptor antagonists as therapeutics for inflammatory disease: Preclinical and clinical developments. Expert Opin Investig Drugs 16, 1909\u20131920 (2007).","journal-title":"Expert Opin Investig Drugs"},{"key":"31192_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"31192_CR29","doi-asserted-by":"crossref","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings. J. Chem. Inf. Model 61:3891\u20138 (2021).","DOI":"10.1021\/acs.jcim.1c00203"},{"key":"31192_CR30","unstructured":"MedChemExpress. n.d. www.medchemexpress.com."},{"key":"31192_CR31","unstructured":"Han Y, Lim J, Tummanapalli S, Siliphaivanh P, Spencer K. Aryl acylsulfonamides as BLT1 antagonists. 10,336,733 (2019)."},{"key":"31192_CR32","unstructured":"Research Collaboratory for Structural Bioinformatics Protein Data Bank (RCSB PDB). n.d."},{"key":"31192_CR33","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","volume":"234","author":"A \u0160ali","year":"1993","unstructured":"\u0160ali, A. & Blundell, T. L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779\u2013815 (1993).","journal-title":"J. Mol. Biol."},{"key":"31192_CR34","unstructured":"Schr\u00f6dinger Release 2024-2: Maestro Viewer (2024)."},{"key":"31192_CR35","unstructured":"Schr\u00f6dinger Release 2024-2: Protein Preparation Workflow (2024)."},{"key":"31192_CR36","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785\u20132791 (2009).","journal-title":"J. Comput. Chem."},{"key":"31192_CR37","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/jcc.540110404","volume":"11","author":"BH Besler","year":"1990","unstructured":"Besler, B. H., Merz, K. M. Jr. & Kollman, P. A. Atomic charges derived from semiempirical methods. J. Comput. Chem. 11, 431\u2013439 (1990).","journal-title":"J. Comput. Chem."},{"key":"31192_CR38","unstructured":"The PyMOL Molecular Graphics System (2024)."},{"key":"31192_CR39","doi-asserted-by":"crossref","unstructured":"MarvinView Version 23.16.0 (2023).","DOI":"10.5962\/p.385618"},{"key":"31192_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-3-1","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle, N. M. et al. Open babel: An open chemical toolbox. J. Cheminform 3, 1\u201314 (2011).","journal-title":"J. Cheminform"},{"key":"31192_CR41","doi-asserted-by":"crossref","unstructured":"Halgren TA. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J. Comput. Chem. 17:490\u2013519 (1996).","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P"},{"key":"31192_CR42","doi-asserted-by":"crossref","unstructured":"Halgren TA. Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions. J. Comput. Chem. 17:520\u201352 (1996).","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<520::AID-JCC2>3.0.CO;2-W"},{"key":"31192_CR43","doi-asserted-by":"publisher","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","volume":"51","author":"S Kim","year":"2023","unstructured":"Kim, S. et al. PubChem 2023 update. Nucleic Acids Res. 51, D1373\u2013D1380 (2023).","journal-title":"Nucleic Acids Res."},{"key":"31192_CR44","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1021\/acs.jcim.6b00283","volume":"56","author":"C Empereur-Mot","year":"2016","unstructured":"Empereur-Mot, C., Zagury, J.-F. & Montes, M. Screening explorer\u2013an interactive tool for the analysis of screening results. J. Chem. Inf. Model 56, 2281\u20132286 (2016).","journal-title":"J. Chem. Inf. Model"},{"key":"31192_CR45","doi-asserted-by":"crossref","unstructured":"Fu L, Shi S, Yi J, Wang N, He Y, Wu Z, Peng J, Deng Y, Wang W, Wu C. ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Res 52:W422\u201331 (2024).","DOI":"10.1093\/nar\/gkae236"},{"key":"31192_CR46","unstructured":"Schr\u00f6dinger Release 2025\u20131: Desmond Molecular Dynamics System (2025)."},{"key":"31192_CR47","unstructured":"Schr\u00f6dinger Release 2025\u20131: Maestro-Desmond Interoperability Tools (2025)."},{"key":"31192_CR48","doi-asserted-by":"crossref","unstructured":"Bowers KJ, Chow DE, Xu H, Dror RO, Eastwood MP, Gregersen BA, Klepeis JL, Kolossvary I, Moraes MA, Sacerdoti FD, Salmon JK, Shan Y, Shaw DE. Scalable algorithms for molecular dynamics simulations on commodity clusters. Proceedings of the ACM\/IEEE Conference on Supercomputing (SC06), IEEE, p. 43\u201343 (2006).","DOI":"10.1109\/SC.2006.54"},{"key":"31192_CR49","doi-asserted-by":"crossref","unstructured":"Berendsen HJC, Postma JPM, van Gunsteren WF, Hermans J. Interaction models for water in relation to protein hydration. Intermolecular Forces: Proceedings of the Fourteenth Symposium on Quantum Chemistry and Biochemistry, Springer, p. 331\u201342 (1981).","DOI":"10.1007\/978-94-015-7658-1_21"},{"key":"31192_CR50","unstructured":"Schr\u00f6dinger Release 2025\u20131: Force Fields (2025)."},{"key":"31192_CR51","doi-asserted-by":"publisher","first-page":"11225","DOI":"10.1021\/ja9621760","volume":"118","author":"WL Jorgensen","year":"1996","unstructured":"Jorgensen, W. L., Maxwell, D. S. & Tirado-Rives, J. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J. Am. Chem. Soc. 118, 11225\u201311236 (1996).","journal-title":"J. Am. Chem. Soc."},{"key":"31192_CR52","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1021\/ar000033j","volume":"33","author":"PA Kollman","year":"2000","unstructured":"Kollman, P. A. et al. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc. Chem. Res. 33, 889\u2013897 (2000).","journal-title":"Acc. Chem. Res."},{"key":"31192_CR53","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1002\/prot.23106","volume":"79","author":"J Li","year":"2011","unstructured":"Li, J. et al. The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling. Proteins Struct. Funct. Bioinf. 79, 2794\u20132812 (2011).","journal-title":"Proteins Struct. Funct. Bioinf."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31192-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31192-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31192-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:20:37Z","timestamp":1768472437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31192-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["31192"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-31192-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1675"}}